Cargando…
Current Advances and Future Strategies for BCL-2 Inhibitors: Potent Weapons against Cancers
SIMPLE SUMMARY: The development of BCL-2 inhibitors as a pivotal approach in cancer treatment lies in their ability to effectively trigger apoptosis in tumor cells. Venetoclax, a highly selective BCL-2 inhibitor, has exhibited robust antitumor capacity in hematologic malignancies. However, patients...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605442/ https://www.ncbi.nlm.nih.gov/pubmed/37894324 http://dx.doi.org/10.3390/cancers15204957 |